Form D · Pharmaceuticals
OnKure, Inc.
Boulder, CO · CIK 0001533914
Offering snapshot reported Apr 3, 2023 · SEC filing
- Reported sold
- $53.8M Offering amount: $60M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 24, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 3, 2023 | Initial | $53,783,369 | No comparison | 15 | SEC filing |
| Mar 4, 2022 | Amendment | $56,649,181 | $27,499,996vs Mar 5, 2021 | 11 | SEC filing |
| Mar 5, 2021 | Initial | $29,149,185 | No comparison | 11 | SEC filing |
| Sep 30, 2020 | Amendment | $1,500,000 | $500,000vs Aug 6, 2020 | 2 | SEC filing |
| Aug 6, 2020 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Apr 15, 2020 | Initial | $3,236,935 | No comparison | 6 | SEC filing |
| Mar 6, 2020 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Sep 20, 2019 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Feb 8, 2018 | Initial | $4,957,450 | No comparison | 16 | SEC filing |
| Jun 8, 2017 | Amendment | $855,000 | $360,000vs Jul 7, 2015 | 8 | SEC filing |
| Jul 7, 2015 | Initial | $495,000 | No comparison | 7 | SEC filing |
| Jun 4, 2013 | Initial | $599,705 | No comparison | 2 | SEC filing |
| Apr 9, 2013 | Amendment | $499,985 | $399,988vs Oct 31, 2011 | 1 | SEC filing |
| Oct 31, 2011 | Initial | $99,997 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-477677
Source: Form D, filed Apr 3, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| R. Michael Carruthers | Director |
| Micheal Carruthers | Director |
| John De Mattei | Executive |
| Zhao Guabao | Director |
| Zhao Guobao | Director |
| Jason Leverone | Executive |
| Xuedong Liu | Director, Executive |
| Isaac Manke | Director |
| Keith M. Olivia | Executive |
| Donna Peak | Director |
| Ken Peak | Director, Executive |
| Andrew J. Phillips | Director |
| Anthony D. Piscopio | Director, Executive |
| Joseph Romano | Director |
| Nicholas Saccomano | Director |
| Duncan Walker | Executive |
| James Winkler | Executive |
| Guobao Zhao | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6707 Winchester Circle Suite 400
Boulder, CO, 80301
Boulder, CO, 80301